Medical News
Latest news
153 articles · 20 / page

Managing Chronic Kidney Disease-Associated Pruritus: Advances and Clinical Strategies
CKD-associated pruritus affects up to 85% of dialysis patients and significantly impairs quality of life. Stepwise management, including novel therapies like nemolizumab, is essential for effective symptom control and improved patient outco

Physical Activity Trajectories Before and After Cardiovascular Disease: Insights from the CARDIA Study
Longitudinal data from CARDIA reveal declining physical activity before and after CVD events, with pronounced disparities among Black women, highlighting the need for targeted interventions across the life course.

Structured Lifestyle Intervention Shows Superior Cognitive Benefits in At-Risk Older Adults: Insights from the US POINTER Trial
A large US trial shows that intensive, structured lifestyle programs yield greater cognitive improvement in at-risk older adults compared to self-guided approaches, though both are beneficial.

The Truth Behind the 10,000 Steps Myth: How Much Walking Is Really Enough?
New research shows walking 7,000 steps daily offers substantial health benefits, debunking the long-held belief in the 10,000-step rule.

Lecanemab in Community Practice: Real-World Safety and Efficacy for Early Alzheimer’s Disease
Community-based data suggest lecanemab is safe and effective for early-stage Alzheimer’s, with manageable ARIA rates and infusion reactions, particularly in ApoE4 noncarriers.

Structured Lifestyle Interventions Deliver Superior Cognitive Benefits over Self-Guided Approaches in At-Risk Older Adults
A large phase 3 trial reveals that structured, multidomain lifestyle interventions significantly improve cognition in older adults at risk for cognitive decline, outperforming self-guided strategies.

Alzheimer’s Association Releases First Clinical Guidelines for Blood-Based Biomarkers: Implications for Diagnosis and Practice
New Alzheimer’s Association guidelines endorse blood-based biomarkers as diagnostic adjuncts, not standalone tests, emphasizing rigorous clinical evaluation and high test accuracy.

Synthetic Opioid Overdose Deaths Among Youth Surge 168%: A Five-Year Analysis and Clinical Implications
Overdose deaths from synthetic opioids alone in U.S. youth aged 15–24 surged 168% between 2018 and 2022, now representing one-third of all youth OD fatalities. Clinical vigilance, harm reduction, and targeted prevention are urgently needed.

CBD Use Among Elective Sports Surgery Patients Highlights Demand for Opioid Alternatives in Pain and Sleep Management
A recent survey found 39% of elective sports surgery patients used CBD for pain or sleep, with one-third reporting benefit—underscoring the need for more evidence and opioid alternatives.

FDA Panel Reviews SSRI Use During Pregnancy: Balancing Fetal Risks and Maternal Mental Health
An FDA expert panel debates the risks and benefits of SSRI antidepressants in pregnancy, emphasizing the need to weigh untreated depression risks against potential drug-related fetal outcomes.

Long Daytime Naps and Short Nighttime Sleep Linked to Triple the Risk of Atrial Fibrillation: Insights from a Spanish Cohort Study
Extended daytime naps and inadequate nighttime sleep independently and synergistically elevate the risk of incident atrial fibrillation, according to a large Spanish cohort study.

AI-Designed Proteins Revolutionize Personalized Cancer Treatment
AI-powered protein design offers a fast, personalized approach to cancer treatment, enhancing immune response and minimizing side effects.
A New Era in Precision Cancer Therapy: AI-Designed Proteins Pave the Way for Personalized Treatment
Researchers developed an AI platform designing proteins that direct immune cells to target cancer precisely, accelerating personalized immunotherapy from years to weeks. This breakthrough enables rapid, specific treatments, promising safer,
Browse by specialty
Open language-specific specialty feeds and department pages.